BioMed Research International / 2014 / Article / Tab 4 / Review Article
Implications of Heterogeneity in Multiple Myeloma Table 4 GEP-based prognostic signatures.
GEP signature Methods UAMS 70-gene [49 ] Derived by comparing expression of profiles of patients with top and bottom quartile of survival treated on total therapy II IFM signature [50 ] Derived by comparing expression of profiles of patients with good and poor outcome in IFM trials Centrosome index [51 ] Based on expression of constituents of the centrosome HZD cell death signature [52 ] Signature derived from genes homozygously deleted in myeloma as detected by array comparative genomic hybridization IL6-HMCL signature [53 ] 13-gene signature from genes induced upon IL6 stimulation of human myeloma cells lines Proliferation index [54 ] Curated signature based on proliferation genes EMC 92-gene signature [55 ] 92-gene signature based on differentially expressed genes between patient with good and poor outcome on HOVON trial Chromosome instability genomic event count (CINGEC) signature [56 ] Based on differentially expressed genes between patients with the top and bottom quartile of genomic instability score based on number of genetic abnormalities identified by array comparative genomic hybridization